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Abstract In order to characterize the domain organization of
sarcoplasmic reticulum Ca2+-ATPase in different physiological
states, limited proteolysis using three proteases (proteinase K
(prtK), V8 and trypsin) was conducted systematically and
quantitatively. The differences between E2 and E2P were
examined in our previous study and E2P was characterized by
the complete resistance to all three proteases (except for trypsin
attack at the very top of the molecule (T1 site)). The same
strategies were employed in this study for E1ATP, E1PADP and
E1P states. Because of the transient nature of these states, they
were either stabilized by non-hydrolyzable analogues or made
predominant by adjusting buffer conditions. Aluminum fluoride
(without ADP) was found to stabilize E1P. All these states were
characterized by strong (E1ATP) to complete (E1PADP and
E1P) resistance to prtK and to V8 but only weak resistance to
trypsin at the T2 site. Because prtK and V8 primarily attack the
loops connecting the A domain to the transmembrane helices
whereas the trypsin T2 site (Arg198) is located on the outermost
loop in the A domain, these results lead us to propose that the A
domain undergoes a large amount of rotation between E1P and
E2P. Combined with previous results, we demonstrated that four
states can be clearly distinguished by the susceptibility to three
proteases, which will be very useful for establishing the conditions
for structural studies. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Sarcoplasmic reticulum (SR) Ca2-ATPase is a 110 kDa
membrane protein and a representative member of P-type
ion transporting ATPases. It catalyzes Ca2 transport coupled
with ATP hydrolysis [1,2]. According to the E1/E2 theory, the
enzyme with bound Ca2 (E1) is autophosphorylated by ATP
bound at the catalytic site to form ADP-sensitive phosphoen-
zyme (E1P). This phosphorylation causes the bound Ca2 ions
to be occluded at the transport sites, and the subsequent con-
formational transition to the ADP-insensitive form (E2P) re-
leases Ca2 into the lumen. Finally, dephosphorylation takes
place and returns the enzyme into the unphosphorylated and
Ca2-unbound E2 form (for recent reviews, see [3,4]).
Ca2-ATPase has three cytoplasmic domains (A, N and P),
which are widely separated in the crystal structure with bound
Ca2 ([5], CaE1 in Fig. 1). It has been proposed that when
Ca2 is absent, three cytoplasmic domains gather to form a
single headpiece. This was based on the modeling of the en-
zyme in tubular crystals formed in the presence of decavana-
date and in the absence of Ca2 ([5], E2V in Fig. 1). Then, an
obvious and important issue to be addressed now is in which
steps in the catalytic cycle such large domain movements take
place. We would like to know if the movement of A domain is
co-ordinated with the movement of N domain, and if the
binding of ATP itself a¡ects the domain organization. To
answer these questions we believe that, although very classic,
limited proteolysis is useful, because these proteases cleave
quite distinct sites (Fig. 1). Proteinase K (prtK) cleaves pri-
marily the loops connecting A domain to M2 and M3 trans-
membrane helices [6], V8 the loop connecting A domain to
M3 helix [7]; trypsin attacks the outermost loop of A domain
(T2 site) in addition to the loop at the top of N domain (T1
site) [8]. We ¢rst studied the di¡erence between E2 and E2P
[10] and demonstrated that E2P is characterized by the com-
plete resistance to all the three proteases (except for trypsin
attack at T1 site). Because of the same resistance properties,
the enzyme in the tubular crystals (E2V) was identi¢ed to be
in a state very close to E2P. These results provided a strong
support for the proposal that A domain rotates a large
amount, because the protection of T2 site by P domain re-
quires a nearly 90‡ rotation of A domain.
We now extend the same strategies to E1ATP complex and
E1P to complete the characterization by limited proteolysis of
various states in the catalytic cycle. The design of the experi-
ments is as follows. Although it is impossible to stop the
reaction in E1ATP state, we could use non-hydrolyzable ana-
logues (adenosine 5P-(L,Q-methylene)triphosphate (AMPPCP)
in this study) to mimic E1ATP; the e¡ect of Q-phosphate can
be addressed by comparing with ADP. 2P,3P-O-(2,4,6-Trinitro-
cyclohexadienylidene) (TNP)-AMP and TNP-ATP may also
be useful for deciphering the e¡ects of di¡erent parts of ATP.
The E1PADP state can be made with Al3/F3/ADP [11]. We
also show that Al3/F3 alone (without ADP) stabilizes E1P.
The E1P to E2P transition can be blocked partially by adding
a high concentration of Ca2 or completely by using N-ethyl-
maleimide (NEM)-treated specimen [12]. We report here that
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E1P and E1ATP have similar patterns of susceptibility, but
distinctly di¡erent from those examined previously, including
E2P [10]. Taken altogether, we can now distinguish four states
unequivocally by limited proteolysis. The results also indicate
that the large rotation of A domain will take place between
E1P and E2P.
2. Materials and methods
2.1. Preparation of SR vesicles and treatment with NEM
SR vesicles were prepared from rabbit skeletal muscle as described
previously [13]. The content of phosphorylation site determined with
32Pi according to Barrabin et al. [14] was 5.0 þ 0.2 nmol/mg of vesicle
protein (n = 6). The Ca2-dependent ATPase activity determined at
25‡C as described previously [13] was 2.51 þ 0.05 Wmol/min/mg of
vesicle protein (n = 3). SR vesicles were treated with NEM in the
presence of adenosine 5P-(L,Q-imido)triphosphate (AMPPNP) accord-
ing to Kawakita et al. [12]. The content of phosphorylation site was
una¡ected and the Ca2-dependent ATPase activity was completely
suppressed by this treatment due to blocking of the E1P to E2P tran-
sition [12,15]. The NEM-treated vesicles were used in some proteolysis
experiments with ATP.
2.2. Proteolysis of SR vesicles
SR vesicles (0.3 mg/ml of vesicle protein) were digested with prtK,
V8 protease, or trypsin in a bu¡er containing 0.1 M KCl, 7 mM
MgCl2, 0.5 mM CaCl2 plus 0.4 mM EGTA (0.103 mM Ca2 at pH
6.7) or 20 mM CaCl2 without EGTA, and 50 mM 3-(N-morpholino)-
propanesulfonic acid/Tris (pH 6.7) or 50 mM 2-(N-morpholino)etha-
nesulfonic acid/Tris (pH 6.0), as stated in the legends for ¢gures and
tables. The concentration (mg/ml) of the protease and temperature
were 0.05 (pH 6.7) or 0.1 (pH 6.0) and 25‡C for the prtK proteolysis,
0.065 (pH 6.7 and pH 6.0) and 37‡C for the V8 proteolysis, and 0.03
(pH 6.7) or 0.1 (pH 6.0) and 25‡C for the tryptic proteolysis, respec-
tively. For the V8 proteolysis, octaethylene glycol monododecyl ether
at a non-solubilizing low concentration of 0.05 mg/ml was included in
the reaction mixture as described previously [7]. E¡ects of ATP and its
analogues were examined with ATP ( þ 5 mM), AMPPCP ( þ 1 mM),
ADP ( þ 100 WM), TNP-AMP ( þ 10 WM) and TNP-ATP ( þ 10 WM),
unless otherwise stated. ATP was added 5 s before the start of the
proteolysis, and other nucleotides 5 min before the start. When the
e¡ects of Al3/F3/ADP/Mg2 were examined, SR vesicles were pre-
incubated essentially according to Troullier et al. [11] with AlCl3
( þ 50 WM), KF ( þ 3 mM), ADP ( þ 100 WM) and MgCl2 ( þ 7 mM)
for 40 min at 22‡C and pH 6.7 in the presence of 0.1 mM Ca2, and
then the proteolysis was started.
Proteolysis was terminated by adding ice-cold trichloroacetic acid
to 2.5% (w/v) and diluting three times with a modi¢ed Laemmli sam-
ple bu¡er containing 3% (w/v) sodium dodecyl sulfate (SDS). 20 Wl of
each sample thus obtained was loaded on a 10.5% gel for SDS^poly-
acrylamide gel electrophoresis according to Laemmli [16]. For better
resolution of the peptides on SDS gels, 1 mM CaCl2 was included in
both the stacking and separating gels for the V8- and prtK-treated
samples [7]. The gels were stained by Coomassie brilliant blue R-250,
and subjected to densitometric analysis with a GT9500-GT95FLU
£atbed scanner (Epson, Tokyo, Japan) and Scion Image software
(Scion Corp., Frederick, MD, USA).
2.3. Miscellaneous methods
V8 protease, prtK, trypsin (L-1-tosylamido-2-phenylethyl chloro-
methyl ketone-treated) were obtained from Sigma. AMPPCP and
AMPPNP were also from Sigma. TNP-AMP and TNP-ATP were
synthesized according to Hiratsuka [17]. Protein concentrations were
determined by the method of Lowry et al. [18] with bovine serum
albumin as a standard. Data were analyzed by non-linear regression
using the program Origin (Microcal Software, Inc., Northampton,
MA, USA).
3. Results
3.1. Degradation of SR Ca2+-ATPase by proteases
Proteolysis of SR Ca2-ATPase in the presence of Ca2 was
carried out using prtK, V8 protease and trypsin to examine
the e¡ects of ATP, AMPPCP, ADP, TNP-AMP, TNP-ATP,
Al3, F3 and Mg2. Typical digestion patterns with prtK and
trypsin are shown in Fig. 2. The degradation of the 110 kDa
ATPase chain with prtK measured by densitometric scan of
the SDS gels was well approximated by ¢rst order reaction
Fig. 1. Location of proteolytic cleavage sites on SR Ca2-ATPase. The positions of the main digestion sites by prtK [6], V8 [7] and trypsin [8]
are shown on the atomic model of Ca2-ATPase [5] with bound Ca2 (CaE1 ; PDB accession code 1EUL) and that made for the decavana-
date-bound form in the absence of Ca2 (E2V; PDB accession code 1FQU), which is analogous to E2P [10]. The arrows in broken lines show
the movements of A and N domains required to ¢t the atomic model of the Ca2-bound state (CaE1) to that of E2V.
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kinetics (Fig. 2A,C). In all the trypsin digestion experiments,
the cleavage at T1 site (Arg505) was very rapid and produced
A and B fragments. The formation of the C-terminal A1 frag-
ment upon further cleavage of A fragment at the T2 site
(Arg198) and its subsequent degradation were well described
by consecutive ¢rst order reaction kinetics (Fig. 2B,D). All the
major digestion products by prtK, V8 and trypsin were found
to be consistent with those published previously [6^9,19^22].
Only the relative rate constants for the degradation of 110
kDa ATPase chain (prtK and V8 proteolysis) and those for
the formation of A1 fragment (trypsin proteolysis) are there-
fore listed in Tables 1^3. Table 1 summarizes the e¡ects of
nucleotide binding. The numbers for stable E1P analogues are
given in Table 2. Table 3 summarizes the experiments with
ATP.
3.2. E¡ects of nucleotides on digestion of SR Ca2+-ATPase
The e¡ects of nucleotide binding to Ca2-ATPase in the
presence of 0.1 mM Ca2 and 7 mM MgCl2 were examined
with AMPPCP, ADP, TNP-AMP and TNP-ATP (Table 1).
AMPPCP, a non-hydrolyzable ATP analogue that will ¢x the
enzyme in the E1ATP state [13,23^25], was clearly di¡erent
from others. Only AMPPCP provided strong resistance
against prtK and V8, and protected A1, A2 and B tryptic
fragments from further degradation. TNP-ATP did not
show such protection e¡ects. On the other hand, none of
the nucleotides provided strong resistance to trypsin cleavage
at the T2 site, although AMPPCP somewhat slowed down the
degradation process. TNP-ATP even accelerated the degrada-
tion. Thus the Q-phosphate was essential for these protections
but the TNP moiety impaired them.
3.3. E¡ects of Al3+, F3, ADP and Mg2+ on digestion of SR
Ca2+-ATPase
Aluminum £uorides (AlF3 and AlF34 ) have been used
widely as Q-phosphate analogues for ATPases and GTPases
[11,26^29]. With Ca2-ATPase, Troullier et al. [11] demon-
strated that AlF34 and ADP make a stable complex with the
enzyme in the presence of Ca2 and Mg2, presumably ¢xing
the enzyme in E1PADP, the state immediately after phosphor-
ylation with ATP. Digestion experiments with this complex
showed complete resistance to prtK and to V8, but only a
weak resistance to trypsin (Table 2). We then examined the
protection e¡ects for all the possible combinations of the four
components (i.e. Al3, F3, ADP, Mg2), and found that Al3/
F3/ADP (no Mg2) and Al3/F3/Mg2 were also equally ef-
fective. Hence we consider that the complex of Ca2-ATPase
with Al3/F3/ADP represents E1PADP whereas Al3/F3/
Mg2 represents E1P and that they have similar compact do-
main organizations. Judging from the digestion rates of the
110 kDa ATPase chain and those at the tryptic T2 site, the
domain organizations in E1PADP and E1P are close to that in
E1ATP, but distinctly di¡erent from that in E2P (completely
resistant to trypsin attack at the T2 site [10]).
3.4. E¡ects of ATP on digestion of SR Ca2+-ATPase
To make the enzyme predominantly in the E1P state with
the natural substrate (ATP), we tried two ways. The ¢rst was
to add 20 mm Ca2 (in the presence of K) so that the tran-
sition from E1P to E2P is largely blocked; low pH (pH 6) was
chosen to avoid too rapid exhaustion of ATP. As expected,
nearly complete protection was found against prtK and V8
(Table 3). The second was to use NEM-treated specimen with
which the E1P to E2P transition is completely blocked [12,15].
With this specimen, complete protection against prtK and V8
was observed even at pH 6.7 and low Ca2 concentration
(0.1 mM).
4. Discussion
As described, E1ATP, E1PADP and E1P states of SR Ca2-
ATPase can now be characterized by a strong resistance to
Table 1
E¡ects of AMPPCP, ADP, TNP-AMP and TNP-ATP on the degradation rate of SR Ca2-ATPase
Protease Relative rate constant (%)
No ligands AMPPCP ADP TNP-AMP TNP-ATP
PrtK 100 15 (36) 100 70 70
V8 protease 100 9 (7) 90 102 104
Trypsin (T2) 100 63 (89) 85 79 128
SR vesicles were digested with prtK, V8 and trypsin at pH 6.7 in the presence of Ca2 (0.1 mM), Mg2 (7 mM) and nucleotides, as described
in Section 2. The rate constants given are those for the degradation of the 110 kDa Ca2-ATPase polypeptide chain (prtK and V8) and those
for the formation of A1 fragment (trypsin, cleavage at Arg198 (T2)). The numbers were obtained by least-squares ¢t as described in Fig. 2 and
given in percentages to those obtained in the absence of nucleotides (no ligands). The numbers in parentheses show the rates in the presence of
AMPPCP but in the absence of Mg2 ; they were normalized to the rates in the absence of both AMPPCP and Mg2 (100%). The results ob-
tained with AMPPCP at 3 mM, ADP at 0.5 mM, and TNP-AMP and TNP-ATP at 30 (and 3) WM (data not shown) were almost the same as
those listed above obtained with AMPPCP at 1 mM, ADP at 0.1 mM, and TNP-AMP and TNP-ATP at 10 WM, respectively.
Table 2
E¡ects of Al3, F3 and ADP on the degradation rate of SR Ca2-ATPase
Protease Relative rate constant (%)
No ligands Al3/F3/ADP Al3/F3 Al3/ADP ADP/F3 F3 Al3 ADP
PrtK 100 2, 0 (1) 8 (56) 93 60 101 111 100
V8 protease 100 0 (0) 0 (83) 101 70 50 108 90
Trypsin (T2) 100 71 (76) 64 (125) 100 68 87 93 85
SR vesicles were treated with the ligands (Al3, F3 and ADP) at pH 6.7 in the presence of Ca2 (0.1 mM) and Mg2 (7 mM), and then di-
gested with prtK, V8 and trypsin, as described in Section 2. Refer to Table 1 for the meaning of the ‘relative rate constant’. The numbers in
parentheses show the degradation rates in the presence of the ligands but in the absence of Mg2 ; they were normalized to the rates in the ab-
sence of both the ligands and Mg2 (100%).
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prtK and to V8 but a weak resistance to trypsin at the T2 site.
This is in marked contrast with E2P, which is characterized by
complete resistance to all of these [10]. The protection against
prtK and V8 was somewhat less in E1ATP stabilized by
AMPPCP than in E1P. This di¡erence will probably be ex-
plained by the equilibrium between E1 and E1AMPPCP, con-
sidering that digestion proceeds irreversibly if the population
of enzyme in E1 state exists at all. Thus, combined with our
previous results [10], four states in the reaction cycle (E1,
E1ATP or E1P, E2P and E2) can be distinguished by their
characteristic di¡erences in the susceptibilities to three pro-
teases, which can be quantitated simply by relative digestion
rates (Table 4).
Then the question is how these proteolysis results can be
interpreted in the light of three-dimensional (3D) structure.
Can we consider in a simple minded way that the decreases
in degradation rate constants represent the steric blocks of the
cleavage sites? Of course we cannot exclude the possibility
that conformational changes unrelated to domain movements
altered the susceptibility of the cleavage sites. However, 3D
structure modeled for vanadate-induced tubular crystals ([5],
E2V in Fig. 1; analogous to E2P) and that determined for
Mg2/F3 complex (a stable E2P analogue [30^33]; Toyoshima
et al., unpublished results) showed that all the cleavage sites
are blocked sterically by gathering of all three cytoplasmic
domains. Hence in the following discussion, we simply relate
the protection e¡ects with steric blocking due to domain
movements schematized in Fig. 3.
The simplest interpretation of the observed protections in
E1ATP and E1P is that N and P domains are in closed con-
¢guration crosslinked by ATP (having adenosine on one end
and Q-phosphate on the other end), by Al3/F3/ADP or Al3/
F3/Mg2 (presumably due to strong interaction of £uoride
with amide nitrogen), or by phosphate covalently bound to
Asp351. Absolute requirement of Q-phosphate for the protec-
tion was evident, because ADP showed no e¡ect for the pri-
mary cleavage site (Glu243) (Table 1). Also reported was a
protection by AMPPNP, another non-hydrolyzable ATP ana-
logue, of A1 and A2 tryptic fragments from further degrada-
tion [20]. Bidentate L,Q-CrATP, which stabilizes the Ca2-oc-
cluded state (analogous to E1P) [34], conferred resistance to
prtK [35] but not to trypsin [21]. It is understandable that the
TNP moiety impaired the protection e¡ects, because TNP-
ATP is virtually non-hydrolyzable with Ca2-ATPase
[36,37]. Presumably, the TNP moiety, which provides much
higher a⁄nity for TNP-ATP than ATP [38,39], prevents prop-
er binding of the ATP moiety to the enzyme and positioning
of Q-phosphate.
Because the adenosine moiety of ATP is considered to bind
around Phe487 in N domain and because the phosphorylation
site (Asp351) on P domain is distant by V25 Aî in the crystal
structure of the Ca2-bound (E1) state [5], very large motion
of domain closure is necessary for the Q-phosphate to reach
the phosphorylation site. In the model for the vanadate-in-
duced tubular crystals (E2V in Fig. 1; analogous to E2P), N
domain is closer to P domain by V20‡ compared to that in
the E1 state; this amount is still too small for bringing the
Q-phosphate to Asp351. This is also true for glutaraldehyde
crosslinking, which is most reactive in E1P but unreactive in
E2P, between Lys492 in N domain and Arg678 in P domain
[40]. Therefore, in the E1ATP and in E1P form, N domain
may come even closer to P domain than in the E2V (E2P)
form (Fig. 3).
Then, it is likely that, in E1ATP and E1P, A domain does
not come to the position in which A and N domains can make
several hydrogen bonds to stabilize the interaction between
them as in E2P. This view is totally consistent with the ob-
servation that the T2 site on A domain is rapidly cleaved in
E1ATP and E1P, but completely resistant in E2P. Therefore, a
large motion of A domain, i.e. rotation by V90‡, and its
strong association with P and N domains occur most likely
during the E1P to E2P transition (Fig. 3).
The large motion of domain closure of N and P domains in
E1ATP and E1P will inevitably cause distortion in P domain,
at least in the half closer to N domain. In fact, £uorescence
from EDANS attached to Cys674 in that half of P domain
changes greatly on the formation of E1ATP (and only slightly
by going further into E1P) [23^25,41]. The distortion will
likely cause the movement of M3 and the loop connecting
A domain (possibly through the hydrogen bond between
Glu340 on PK1 and Thr247 (see ¢gure 8 in [5]), or through
the interaction with the loop connecting M6 and M7 because
the mutations there slow down the phosphorylation [42]).
Then, ‘in E1ATP and E1P, does A domain occupy a posi-
Fig. 2. E¡ects of AMPPCP, TNP-ATP and Al3/F3/ADP on the prtK and trypsin digestion of SR Ca2-ATPase. SR vesicles treated with
Al3, F3 and ADP (Al/F/ADP), and untreated vesicles preincubated with AMPPCP (AMPPCP) and TNP-ATP (TNP-ATP) or without those
ligands (3), were digested with prtK (A, C) and trypsin (B, D) in the presence of 7 mM Mg2 and 0.1 mm Ca2 at pH 6.7, as described in
Section 2. A: SDS gels of the prtK digests, and (B) those of the trypsin digests. The positions of Ca2-ATPase and its proteolytic fragments,
and those of the molecular mass markers are indicated on the right and the left margins, respectively. C: The time courses for the amounts of
the 110 kDa Ca2-ATPase polypeptide chain in prtK digestion with the Al3/F3/ADP-treated (b) and untreated (a, R) vesicles in the absence
(a) or presence (R) of AMPPCP. D: The time courses for the amounts of A1 fragment in trypsin digestion with the Al3/F3/ADP-treated (b)
and untreated (a, R) vesicles in the absence (a) or presence (R) of TNP-ATP. Solid lines in (C) show least-squares ¢t of a single exponential
to the time course for the amounts of the 110 kDa ATPase chain, in which the ¢rst order rate constants (h31) were 0.053 for the Al3/F3/
ADP-treated vesicles, 2.1 for the untreated vesicles, and 0.32 for the untreated vesicles in the presence of AMPPCP. Solid lines in (D) show
least-squares ¢t of a double exponential in a consecutive formation and decay reaction to the time course for the amounts of A1 fragment, in
which the formation rate constants and decay rate constants (h31) were 5.5 and 0.022 for the Al3/F3/ADP-treated vesicles, 7.7 and 0.80 for
the untreated vesicles, and 7.1 and 0.48 for the untreated vesicles in the presence of TNP-ATP.
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Table 3
E¡ects of ATP on the degradation rate of SR Ca2-ATPase
Protease Relative rate constant (%)
No ATP Native SR NEM-modi¢ed SR
PrtK 100 5 (22) 0 (1)
V8 protease 100 2 0a (12a)
Trypsin (T2) 100 68 ND
E¡ects of ATP on prtK, V8 and trypsin digestion of the unmodi¢ed
(native SR) and NEM-modi¢ed (NEM-modi¢ed SR) Ca2-ATPases
were examined at pH 6.0 in the presence of 20 mm CaCl2, or
0.5 mm CaCl2 plus 0.4 mm EGTA (the numbers in parentheses), as
described in Section 2. Refer to Table 1 for the meaning of the ‘rel-
ative rate constant’. ND: not determined.
aDetermined at pH 6.7.
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tion di¡erent from that in E1 ?’ will be the next question.
Probably so. The protection against trypsin attack in E1ATP
and E1P states was far from complete (only to 2/3 in the rate
constant) but signi¢cant. The complete protection against
prtK in these states will imply that the loop connecting M3
and A domain has moved toward and is protected by P do-
main (Fig. 1). The complete protection against V8 means that
the part (around Glu231) of the same loop closer to A domain
has also moved and that the part of P domain (including
Glu715) that makes contacts with the upper part of M3 has
become inaccessible to the protease. Therefore, it is likely that,
in E1ATP and E1P, A domain has moved toward P domain,
but the domain is not yet rotated as in E2P (Fig. 3).
These notions on the domain arrangements are in complete
agreement with the results by Fe-catalyzed cleavage of
Na,K-ATPase. Karlish and co-workers proposed using
this technique [43] that A domain is not in close contact
with P domain in E1ATP and E1P, but is so in E2P. They
showed that TGES sequence (starting from Thr181 with Ca2-
ATPase) comes close to TGDGVND (starting from Thr701
with Ca2-ATPase) in E2P. The location of T2 site (Arg198)
is very close to Glu183 in the 3D structure (Fig. 1; [5]).
All these data support the idea that cytoplasmic domains of
Ca2-ATPase take distinctly di¡erent arrangements in the cat-
alytic cycle, and show that they can be distinguished by lim-
ited proteolysis. The results also strongly suggest that the
Table 4
Relative digestion rates for the intermediates in the catalytic cycle of SR Ca2-ATPase



















100 113 17 0 0 1 0
V8 protease E231(u), E715(s) 100 107 10 0 0 0 0
Trypsin (T2) R198(u) 100 211 133 150 135 0 0
The representative numbers for digestion rates obtained in our present and previous [10] studies for the six major intermediates (E2, E1,
E1ATP, E1PADP, E1P, and E2P) in the catalytic cycle of Ca2-ATPase were summarized together with those for the decavanadate-bound state
without Ca2 (E2V), which forms the tubular crystals [46]. The ligands used for stabilizing individual states are shown in parentheses. In the
prtK and V8 digestion, the rate constants for the degradation of the 110 kDa Ca2-ATPase polypeptide chain were shown. In the trypsin di-
gestion, the rate constants for the cleavage at Arg198 (T2) were shown. The rate constants were normalized to that obtained in the absence of
Ca2 and ligands (E2 (no ligands)) (100%). The primary cleavage sites [6^8] were listed with their C-terminal residues: (u) and (s) indicate the
increase and decrease, respectively, in the cleavage rate of the Ca2-bound state (E1) compared to the unbound state (E2).
aData obtained in this study.
bData obtained in our previous study [10].
Fig. 3. Schematic models for four distinct arrangements of three cytoplasmic domains (N, P and A) in the catalytic cycle of Ca2-ATPase. Ar-
rows indicate the proposed domain movements. In the text and tables, ‘CaE1’ and ‘CaE1ATP’ to ‘CaE1P’ were described without ‘Ca’ for sim-
plicity.
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large rotation of A domain takes place during the E1P to E2P
transition and this rearrangement is likely to be a key event in
the whole reaction cycle. In fact, the enzyme cleaved at Glu231
by V8 can be phosphorylated by ATP but does not undergo
normal enzymatic turnover (due to blocking of the E1P to E2P
transition) [7]. This is also the case with the enzyme cleaved at
Thr242 by prtK [9]. In the enzyme cleaved at T3b site (Lys234
or Arg236) by trypsin, the E1P to E2P transition is blocked
[22]. Mutations of Gly233, which is highly conserved among P-
type ATPases, result in a very slow transition of E1P to E2P
[44]. Furthermore, glutaraldehyde-crosslinked enzyme, pre-
sumably ¢xed in an E1ATP-like con¢guration, does not pro-
ceed from E1P to E2P [40]. All these data suggest that Ca2-
ATPase utilizes A domain for realizing the hydrophobic at-
mosphere [45] around the phosphorylation site in E2P state so
that a speci¢c water molecule can attack the acylphosphate
(Fig. 3). Also the stabilization energy provided by intimate
contacts between all three cytoplasmic domains in E2P will
provide energy for moving transmembrane helices and release
bound Ca2 ions.
Finally, for structural studies of intermediate states, it is
vital to ¢nd conditions to stabilize them perfectly and e⁄cient
methods for examining how stable they are. The methods and
conditions established in this (for E1P) and our previous (for
E2P) [10] studies must be useful for making good crystals.
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